SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 29th, 2008 • Stereotaxis, Inc. • Electromedical & electrotherapeutic apparatus • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 29, 2008, by and among Stereotaxis, Inc., a Delaware corporation, with headquarters located at 4320 Forest Park Avenue, Suite 100, St. Louis, Missouri 63108 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
2,389,877 Shares Series A Warrants to Purchase up to 1,792,408 Shares Series B Warrants to Purchase up to 2,148,739 Shares Series C Warrants to Purchase up to 341,412 Shares Series D Warrants to Purchase up to 341,412 Shares Stereotaxis, Inc. Common...Placement Agency Agreement • December 29th, 2008 • Stereotaxis, Inc. • Electromedical & electrotherapeutic apparatus
Stereotaxis, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this Placement Agency Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the investors identified therein (each, an “Investor” and collectively, the “Investors”), to issue and sell up to an aggregate of (i) 2,389,877 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”), (ii) Series A Warrants to purchase up to 1,792,408 shares of Common Stock (the “Series A Warrants”) in the form attached hereto as Exhibit B-1, (iii) Series B Warrants to purchase up to 2,148,739 shares of Common Stock (the “Series B Warrants”) in the form attached hereto as Exhibit B-2, (iv) Series C Warrants to purchase up to 341,412 shares of Common Stock (the “Series C Warrants”) in the form attached hereto as Exhibit B-3 and (v) Series D Warrants to purcha
